Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,652 public trials 850 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

NCT03454451

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +78 more
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • City Of Hope Duarte, California, United States
  • UC San Francisco San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Completed

Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006)

NCT03483103

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Local Institution - 0043 Gilbert, Arizona, United States
  • Scripps Clinic La Jolla, California, United States
  • UNC School of Medicine Los Angeles, California, United States
View all 59 locations
View Trial Details
Completed

Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

NCT02561273

Conditions
Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Enteropathy-Associated T-Cell Lymphoma, +21 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
View Trial Details
Completed

CREATE: Cross-tumoral Phase 2 With Crizotinib

NCT01524926

Conditions
Granuloma, Granuloma, Plasma Cell, Hemic and Lymphatic Diseases, +27 more
Locations
  • Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
  • U.Z. Gasthuisberg Leuven, Belgium
  • Institut Bergonie Bordeaux, France
  • Centre Georges-Francois-Leclerc Dijon, France
View all 25 locations
View Trial Details
Completed

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

NCT03436862

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +10 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • HCA Midwest Kansas City, Missouri, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • St. David's South Austin Medical Center Austin, Texas, United States
View Trial Details

Related conditions